342 related articles for article (PubMed ID: 17272742)
1. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis.
Sumi M; Sata M; Miura S; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):813-8. PubMed ID: 17272742
[TBL] [Abstract][Full Text] [Related]
2. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
3. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL.
Pu DR; Liu L
Med Hypotheses; 2008; 70(2):338-42. PubMed ID: 17640824
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
[TBL] [Abstract][Full Text] [Related]
7. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia.
Iwase T; Nagaya N; Fujii T; Itoh T; Ishibashi-Ueda H; Yamagishi M; Miyatake K; Matsumoto T; Kitamura S; Kangawa K
Circulation; 2005 Jan; 111(3):356-62. PubMed ID: 15655128
[TBL] [Abstract][Full Text] [Related]
10. Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway.
Zhang Q; Yin H; Liu P; Zhang H; She M
Exp Biol Med (Maywood); 2010 Sep; 235(9):1082-92. PubMed ID: 20724534
[TBL] [Abstract][Full Text] [Related]
11. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146
[TBL] [Abstract][Full Text] [Related]
14. Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia.
Kim HW; Lin A; Guldberg RE; Ushio-Fukai M; Fukai T
Circ Res; 2007 Aug; 101(4):409-19. PubMed ID: 17601801
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
[TBL] [Abstract][Full Text] [Related]
16. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats.
Imaizumi S; Miura S; Nakamura K; Kiya Y; Uehara Y; Zhang B; Matsuo Y; Urata H; Ideishi M; Rye KA; Sata M; Saku K
J Am Coll Cardiol; 2008 Apr; 51(16):1604-12. PubMed ID: 18420105
[TBL] [Abstract][Full Text] [Related]
18. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
